Stocks Health care MDXH
NASDAQ · Health careMDxHealth SA (MDXH)
MDxHealth SA reported revenue of $107.9M in fiscal 2025, up 19.8% from a year earlier. It posted a net loss of $33.5M. In fiscal 2025 capital spending exceeded operating cash flow by $3.3M. At December 31, 2025 it held $29M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 3, 2026.
Key facts about MDxHealth SA
- Net worth
- MDxHealth SA has a market value (market cap) of $13.3M at the latest share price, and shareholders' equity of -$12.1M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $107.9M (+19.8% year on year), with a net loss of $33.5M.
- Cash flow
- In fiscal 2025 operations used $2.2M of cash.
- Latest report
- The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on April 3, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What MDxHealth SA does
MDxHealth SA is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker MDXH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $107.9M | -$33.5M | -$0.67 | -$3.3M |
| 2024 | $90M | -$38.1M | -$1.16 | -$19.7M |
| 2023 | $70.2M | -$43.1M | -$1.66 | -$24.2M |
| 2022 | $37.1M | -$44M | -$2.78 | -$36.9M |
| 2021 | $22.2M | -$29M | $2.38 | -$23.4M |
| 2021 | $18.5M | -$28.7M | $3.37 | -$20.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where MDXH ranks in Health care
Latest SEC filings
What MDxHealth SA has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 3, 2026
- August 17, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Activist stake (5% or more) SCHEDULE 13D
- August 13, 2026
- August 13, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- July 24, 2026
- July 8, 2026Passive stake changed SCHEDULE 13G/A
- July 2, 2026
- May 13, 2026
Insider trades
What the people running MDxHealth SA did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $1M worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 13, 2026 | MVM Partners, LLCDirector | Boughtindirect | 2,202,643 | $1M |
Who owns MDXH
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Bleichroeder LP13D, may seek influence with 2 related filers | 33.2% | August 14, 2026 |
| Laurence W. Lytton13G, passive with 1 related filers | 19.5% | August 17, 2026 |
| Genomic Health, Inc.13G, passive with 1 related filers | 12% | January 16, 2026 |
| MVM Partners, LLC13D, may seek influence with 2 related filers | 9.94% | October 28, 2024 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 26 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Bleichroeder LP | 7,378,333 | 0 |
| MVM Partners, LLC | 4,700,457 | 0 |
| Perkins Capital Management Inc | 1,411,891 | -64,550 |
| Citadel Advisors LLC | 509,674 | +450,040 |
| Jane Street Group, LLC | 503,219 | new |
| Renaissance Technologies LLC | 325,084 | +20,384 |
| Millennium Management LLC | 228,510 | -316,218 |
| Squarepoint Ops LLC | 200,281 | new |
| XTX Topco Ltd | 195,039 | +157,324 |
| BlackRock, Inc. | 147,063 | +42,742 |
| Ground Swell Capital, LLC | 88,114 | new |
| Tower Research Capital LLC (TRC) | 36,549 | new |
| FAS Wealth Partners, Inc. | 22,625 | 0 |
| Lido Advisors, LLC | 20,253 | +9,756 |
| Intesa Sanpaolo Wealth Management | 10,000 | 0 |
| Morgan Stanley | 764 | -15,620 |
| Gsa Capital Partners Llp | 481,985 | +470,893 |
| Wells Fargo & Company | 200 | 0 |
| Hrt Financial LP | 184,477 | +173,154 |
| Virtu Financial LLC | 134,178 | new |
Insiders
1 insiders reported holding 6,903,100 shares in total, about $961.6K at the last price.
| Holder | Shares |
|---|---|
| MVM Partners, LLCDirector | 6,903,1006,903,100 held indirectly |
Questions about MDXH
What does MDxHealth SA do?
MDxHealth SA is a company in the Health care sector, listed on NASDAQ as MDXH. Its shares trade on NASDAQ under the ticker MDXH.
What is MDxHealth SA's net worth?
MDxHealth SA has a market value (market cap) of $13.3M at the latest share price, and shareholders' equity of -$12.1M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is MDxHealth SA profitable?
No. In fiscal 2025 it reported a net loss of $33.5M on revenue of $107.9M.
How much revenue does MDxHealth SA make?
In fiscal 2025 MDxHealth SA reported revenue of $107.9M. That is 19.8% more than a year earlier.
When did MDxHealth SA last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 3, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the planned insider sale from September 17, 2026.
Similar companies
Compare MDXH with
Follow MDXH
Get an email when MDxHealth SA files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values MDxHealth SA tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.